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Abstract
Background: Mendelian randomization studies perform instrumental variable (IV) ana-
lysis using genetic IVs. Results of individual Mendelian randomization studies can be
pooled through meta-analysis. We explored how different variance estimators influence
the meta-analysed IV estimate.
Methods: Two versions of the delta method (IV before or after pooling), four bootstrap es-
timators, a jack-knife estimator and a heteroscedasticity-consistent (HC) variance estimator
were compared using simulation. Two types of meta-analyses were compared, a two-
stage meta-analysis pooling results, and a one-stage meta-analysis pooling datasets.
Results: Using a two-stage meta-analysis, coverage of the point estimate using boot-
strapped estimators deviated from nominal levels at weak instrument settings and/or
outcome probabilities  0.10. The jack-knife estimator was the least biased resampling
method, the HC estimator often failed at outcome probabilities  0.50 and overall the
delta method estimators were the least biased. In the presence of between-study hetero-
geneity, the delta method before meta-analysis performed best. Using a one-stage meta-
analysis all methods performed equally well and better than two-stage meta-analysis of
greater or equal size.
Conclusions: In the presence of between-study heterogeneity, two-stage meta-analyses
should preferentially use the delta method before meta-analysis. Weak instrument bias
can be reduced by performing a one-stage meta-analysis.
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Introduction
Despite considerable effort, observational (i.e. nonrandom-
ized) studies are sensitive to confounding bias and reverse
causation.1-4 To overcome these problems, Mendelian ran-
domization (MR) studies have been advocated, using one
or multiple single nucleotide polymorphisms (SNPs) as an
instrument in instrumental variable (IV) analyses.5,6
In this type of Mendelian randomization study, the ef-
fects of an IV on an intermediate phenotype and on an out-
come are estimated and combined to derive the causal
effect of the intermediate on the outcome. This causal ef-
fect is unbiased if (among others) the following three as-
sumptions hold: (i) the IV is associated with phenotype; (ii)
conditional on the phenotype and the (possibly unmeas-
ured) confounders, the IV is independent of the outcome;
and (iii) the IV is independent of confounders.7
Although the performance of the different IV point esti-
mators has previously been explored,8,9 the performance
of the different variance estimators remains unclear. This is
especially important because, to increase precision,
Mendelian randomization studies often meta-analyse re-
sults from multiple studies. Because of this, different vari-
ance estimators not only impact type-1 error rates and
confidence intervals but may also lead to different point
estimates.
Typically, three types of meta-analysis can be defined:
an aggregated meta-analysis combining study specific re-
sults; a two-stage individual patient data meta-analysis, in
which an analysis script is designed and shared prospect-
ively, before pooling study specific results; an one-stage in-
dividual patient data meta-analysis sharing the actual
datasets. Given the usually straightforward analyses in
genetic epidemiology, the differences between aggregated
meta-analysis and two-stage individual patient data meta-
analysis are often small; therefore here we only differenti-
ate between two-stage meta-analyses and one-stage meta-
analyses. A recent review by Boef et al.10 showed that 47
out of 80 meta-analyses of Mendelian randomization per-
formed a two-staged analysis; among those, 10 performed
IV analysis within each study before combining, whereas 9
combined gene-phenotype and gene-outcome associations
separately before performing IV analysis. We note that
gene scores are also used as instruments;11 using aggre-
gated results this can be implemented, for example, by
meta-analysing aggregated results of the gene-biomarker
and the gene-outcome relationships into two estimates12
and applying the ratio estimator (see Methods).
Alternatively, when individual patient data are available,
gene scores can be implemented using the ‘two-stage least
squared like’ estimator (TSLS, see Methods).
In the present study we used simulations to compare
multiple variance estimators. In addition, an empirical ex-
ample on the effect of low-density lipoprotein cholesterol
(LDL-C) on cardiovascular disease (CVD) is included.
Methods
Simulation set-up
Initially we focus on a two-stage meta-analysis where each
study has information on a single SNP (Z), a continuous
phenotype (X) and a dichotomous endpoint (Y). The goal
is to estimate the causal (marginal) odds ratio (OR) of one
unit of increase in phenotype on the outcome.
Data-generating process
J studies were simulated; for the jth study a disease out-
come, a phenotype and an IV were generated for nj inde-
pendent subjects, where j ¼ 1; . . . ; J. To increase
readability, the following notation is presented for one
study with the same process applied to all studies. The IV
variable, Z; counts the number of minor alleles for the
Key messages
• To increase power Mendelian randomization studies frequently combine study results (two-stage meta-analysis) or
study datasets (one-stage meta-analysis). When conducting a two-stage meta-analysis, different variance estimators
may affect not only coverage or type 1 error rates but also point estimates.
• In two-stage meta-analyses of weak instrument or rare diseases, resampling-based variance estimators are expected
to result in biased point estimates with coverage below 0.95. Two-stage meta-analyses using the delta method are ex-
pected to perform better.
• In the presence of between-study heterogeneity, the delta method applied at stage one of the meta-analysis will likely
result in the least biased estimate with relatively good coverage.
• In one-stage meta-analysis scenarios, point estimates are not influenced by the choice of variance estimator and
coverage is generally similar between the variance estimators. One-stage meta-analyses are, however, still affected
by the size and quality of the included studies.
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ith individual. Following a biallelic model, genotypes were
generated from two independent Bernoulli distributions,
resulting in the usual Hardy-Weinberg proportions:
Prob Z ¼ 0; Z ¼ 1; Z ¼ 2ð Þ ¼ q2; 2pq; p2 :
where p represents the probability of the rare allele and q
¼ 1  p the probability of the major allele. Phenotype X
was generated dependent on Z and an unobserved con-
founder C:
xi ¼ a0 þ a1zi þ a2ci þ ei with ei  N 0; 1ð Þ; ci
 N 0; 1ð Þ:
For the ith individual, the probability of an event was
generated based on X and C:
logit Prob½yi ¼ 1jci; xið Þ ¼ log Prob½yi ¼ 1jci; xi
1  Prob½yi ¼ 1jci; xi
 
¼ d0þd1 a0 þ a1zi þ a2ci þ eið Þ
þ d2ci ¼ d0 þ d1xi þ d2ci;
the event was sampled from a Bernoulli distribution:
yi  Bernoulli Prob yi ¼ 1jci;xi½ ð Þ:
Data analyses
Point estimators
Given that the confounder C is unobserved, it is impos-
sible to estimate the causal effect of the phenotype X on
the outcome using regular methods such as logistic regres-
sion. Instead, SNP Z can be used to estimate the causal ef-
fect of the phenotype on the outcome. The ratio estimator
is a relatively straightforward estimator of the logarithm
of the causal odds ratio (logOR), which is the estimand
here
bh ¼ ðbc1  bd3Þ=ba1: [1]
Where bc1 represents the effect of the SNP on the out-
come measured as the log(OR), bd3 the log(OR) effect of
the SNP on the outcome conditional on the phenotype and
unmeasured confounders and ba1 the mean difference effect
of the SNP on the phenotype (estimated by fitting a linear
regression of the type xi ¼ ba0 þ ba1zi þ ei [2]). If every
confounding variable (C) was measured, bc1 and bd3 could
be estimated by fitting the following (logistic regression)
models: logit Prob½yi ¼ 1jzið Þ ¼ bc0 þbc1zi and logit
Prob½yi ¼ð 1jzi;xi; ciÞ ¼ bd0 þ bd1xi þ bd2ci þ bd3zi. However,
because it is never known if all confounders are measured
(and correctly specified), this strategy is not feasible.
Instead, following the exclusion restriction (assumption ii
above), we assume that bd3 ¼ 0, and equation 1 reduces
to the ratio of bc1 and ba3. This ratio estimator is typically
used when there is a single instrument or when a multi-
gene score is based on a meta-analysis of aggregated
results.12
Instead of the ratio estimator, the ‘two-stage least
squares like’ point estimator (TSLS), also referred to as the
two-stage predictor substitution estimators,13 is used to es-
timate the IV effect using a (weighted) gene score.8
logitðProb yi ¼ 1jbxi½ Þ ¼ bb0 þ bhbxi [3]
where bxi represents the fitted value of a linear model re-
gressing xi on zi (i.e. the fitted values from a linear regres-
sion defined in equation 2).
Variance estimators
Following the usual research practice, we will focus on a
two-stage meta-analysis where in the second stage study
specific results are pooled by the inverse of the variance.14
Because results are pooled by the inverse of the variance,
we initially focus on different variance estimators, exclud-
ing methods that directly estimate a confidence interval.
The delta method15,16 (DM) has the closed form
solution:
br2DM ¼ br2c1ba1ð Þ2 þ br2a1 bc1ð Þ
2
ba1ð Þ4  2br2c1;a1 bc1ba1ð Þ3 : [4]
Where br2c1 represents the estimated variance in bc1, br2a1 the
variance in ba1 and br2c1;a1 the estimated covariance betweenbc1 and ba1. Often the delta method is applied to meta-
analysis settings where br2c1;a1 is set to zero, resulting in a
small overestimation of the variance; this was followed
here. Two versions of the delta method were compared: (i)
calculating the ratio estimator and the br2DM in each study
followed by meta-analysis of bh (DM1); and (ii) calculatingbh using the ratio estimator and br2DM after separately meta-
analysing bc1and ba1 (DM2).
Alternatively, by sampling with replacement from the
observed sample, creating a resampled dataset of size n
and repeating this B times, a non-parametric bootstrapped
distribution17 can be constructed. This distribution can be
used to estimate the variance in the IV point estimate [basic
bootstrap (BB)]:
br2Boot ¼ 1B 1 XB
b ¼ 1
h
  bhb 2 [5]
with bhb the IV estimate estimated in the bth bootstrap
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sample and h

the mean IV estimate over the B bootstrap
samples; here B ¼ 1; 000:
All bootstrap variance estimators assume symmetry
in bootstrap distribution, due to data sparseness, extreme
values of bh may occur, overestimating the br2Boot.
Straightforward solutions that are less sensitive to data
sparseness include a bootstrap stratified for the outcome
[outcome stratified (OS)] or stratified for the SNP status
[SNP stratified (SS)]. A more computer-intensive solution
is to perform a double bootstrap (DB)17 where for every
bth bootstrap sample, R new bootstrap samples of size n
are taken using the bth bootstrap sample as the source
population. For every bth bootstrap sample the variance is
estimated, with the median of these estimates representing
the DB IV variance estimate. In our simulations, R ¼ 50
and BDB ¼ R5. An jack-knife (JK)17 variance estimator
can also be used:
br2jack ¼ n  1n Xn
i ¼ 1
hjack  bhi 2
here hjack represents the mean IV estimate over the n
jack-knife estimates and bhi the IV estimate deleting the ith
observation.
The previous variance estimators were all applied using
the ratio estimator. The robust sandwich (RB)
heteroscedasticity-consistent (HC) variance estimator can
be used for the TSLS IV, in which the variance estimate br2bxy
for bh (equation 3) is replaced by the RB estimate. Here we
used HC1 and note that JK and RB estimators are related
in the sense that the JK approximates the HC3 estimator,
which is a refinement of HC1.18 Note that the HC
estimators are implemented not to adjust for any
heteroscedasticity, but merely to penalize the naive vari-
ance estimator which assumes that the bx in equation 3 is
measured without error.
Simulation scenarios
In all simulations J ¼ 10 studies were generated, with nj
sampled from a uniform distribution (400, 3600) (see
Table 1 for an overview of the simulation parameters). In
scenario I, the minor allele frequency (p) was set to 0.50,
0.10, 0.05, 0.01, and 0.005. The probability of the out-
come was 0.50. To (initially) prevent weak instrument
bias,19 the SNP effect on the phenotype was set to
a1 ¼ 0:50, and the unmeasured confounder effect to
a2 ¼ 1:00. By fixing the SNP-phenotype association and
decreasing p; the explained variance due to the SNP de-
creased, as well as the F-statistic. For example, in scenario
I the average F-statistic was 126, 46, 25, 6 and 5. To simu-
late a large amount of confounding, the log(OR) of the un-
measured confounder effect on the outcome was set to
d2 ¼ 1:50, the phenotype log(OR) was set to d1 ¼ 0:00
(i.e. no causal effect). In scenario II, p was set to 0.15 and
the probability of the outcome was set to 0.10, 0.05, 0.02
and 0.01. Scenarios III and IV differed from II only with re-
spect to p ¼ f0:05; 0:01g.
All simulations were repeated 2000 times and were per-
formed with the statistical package R version 3.1.2 for
Unix.20 The number of replications was chosen to ensure
sufficient precision to detect small deviations from the
nominal coverage rate of 0.95 (the 95% lower and upper
bounds are 0.940 and 0.960).21 Results were pooled using
the inverse variance method following a fixed or random
effects model where appropriate.
Table 1. Simulation scenarios assessing performance of different variance estimators for an instrumental variable analysis
Parameters Scenario I Scenario II Scenario III Scenario IV
Number of studies J 10 10 10 10
Sample size sampled from a uniform
distribution Uða; bÞ
(400, 3600) (400, 3600) (400, 3600) (400, 3600)
Minor allele frequency p {0.50, 0.10, 0.05,
0.01, 0.005}
0.15 0.05 0.01
Effect of SNP on the phenotype a1 0.50 0.50 0.50 0.50
Effect of unobserved confounder
on the phenotype a2
1.00 1.00 1.00 1.00
Intercept a0 0.10 0.10 0.10 0.10
Log(OR) of the phenotype effect
on the outcome d1
0.00 0.00 0.00 0.00
Log(OR) of the unobserved confounder
effect on the outcome d2
1.50 1.50 1.50 1.50
Probability of the outcome 0.50 {0.10, 0.05, 0.02, 0.01} {0.10, 0.05, 0.02, 0.01} {0.10, 0.05, 0.02, 0.01}
Ln(odds) outcome intercept d0 0.00 {-2.20, -2.94, -3.89, -4.60} {-2.20, -2.94, -3.89, -4.60} {-2.20, -2.94, -3.89, -4.60}
Changes from the previous scenario (on the left) are presented in bold. Alphas represent mean differences, betas the natural logarithm of the odds ratio.
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Performance metrics
Results were evaluated using the following metrics. Mean
bias logOR  log½True OR
 
, with the first term repre-
senting the mean of the logdOR; mean standard error (SE),
empirical SE (ESE); estimated by taking the standard devi-
ation of the distribution of logdOR. The root mean squared
error RMSE ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
logOR  log True OR½ 
 2
þ ESE2
r" #
,
coverage rate, defined as the proportion of times the 95%
confidence interval (CI) included the true OR, and the
number of models that failed to return estimates.
Additional analyses
Obviously, the absolute performance of the methods depends
on the mean sample size per study. To explore the performance
in a larger sample size setting, a ‘medium’-sized meta-analysis
of 60 000 subjects was simulated by repeating scenario I.
Instead of combining study results in a two-stage meta-
analysis, one can also combine datasets in a one-stage
meta-analysis. This was explored by repeating scenario I,
concatenating the studies together in a single file and ad-
justing all analyses for study (i.e. bootstrapped by study or
adding a study covariable). Given that results do not have
to be pooled in a second stage, we only report on a single
DM estimator. We instead report on the bootstrap-based
percentile confidence interval22 which directly estimates
the confidence interval (instead of the variance).
In a third sensitivity analysis, scenario I was repeated
introducing between-study variance of the gene-phenotype
association. This was simulated by replacing a0; a1 and ei
by a0j  Nð0:10; 12Þ, a1j  Nð0:50; 12Þ and eij  Nð0;
12j Þ with 12j  Nð1:50; 0:32Þ.
In a fourth sensitivity analysis, we evaluated the per-
formance of (i) using only the first term of the delta
method (the Toby Johnson [TJ] method), and (ii) replacing
the asymptotic variance estimates, br2c1 ; and br2a1 ; in the
delta method (using the first two terms) by bootstrapped
estimates [DM BB]. Both methods were implemented by
applying the algorithms before meta-analysis and after
meta-analysis (i.e, TJ1, TJ2, DM1 BB, and DM2 BB).
Performance was evaluated in scenario I. Additionally, in a
fifth sensitivity analysis, we explored performance for con-
tinuous outcomes; implemented by repeating scenario I
using the parameters of scenario I as mean differences; see
Appendix Figure 1 for a flowchart of the methods eval-
uated (available as Supplementary data at IJE online).
Results
Figure 1 depicts the performance of the IV variance estima-
tors under different minor allele frequencies (MAF) or
instrument strengths (F-statistic). Unless explicitly stated,
all results pertain to the two-stage meta-analysis. At a
MAF of 0.50, pooled odds ratio (OR) estimates of all
methods were unbiased, but differences between the esti-
mators increased as MAF decreased to 0.005 (or F-statistic
went towards zero). Coverage of both the DM estimators
increased towards 1.00 as MAF decreased; the RMSE was
equal for both DM estimators, and smaller than the RMSE
of other methods (Figure 1). JK and RB coverage deterio-
rated towards 0.80 at lower MAFs. Coverage of the boot-
strap methods decreased below 0.95 at a MAF of 0.10/F-
statistic 25, recovering to 0.95 at lower MAFs using the
BB, SS and DB methods. This unexpected behaviour in
coverage was due to the bias in SE (i.e. difference between
mean SE and ESE, see Figure 1; Appendix table 1, available
as Supplementary data at IJE online) trailing behind the
bias in OR. Generally the mean SE and ESE agreed well
for the DM.
In scenarios II-IV the outcome incidence varied from
0.10 to 0.01 and the MAF was set to 0.15, 0.05 or 0.01, re-
spectively (Appendix Tables 2-4, available as
Supplementary data at IJE online). At lower outcome
probabilities, bias in both DM1 and DM2 was similar, and
lower than bias of other methods. For example, in scenario
IV at an outcome probability of 0.05, the mean OR was 1.
339 and 1.572 for DM1 and DM2, respectively. Coverage
of DM1 and DM2 differed substantially at lower outcome
probabilities; for example in scenario IV with an outcome
probability of 0.01, coverage was 0.793 and 0.550, re-
spectively. Differences between ESE and mean SE were
similar however (DM1: -5.729 and DM2: -5.404, respect-
ively), as were the RMSE estimates (DM1: 3.268 and
DM2: 3.670, respectively). Coverage of the JK and boot-
strap methods was similar and decreased below 0.95 at
lower outcome probabilities. RMSE was also similar for
all resampling methods, and higher than the DM methods.
RB estimates were the most biased, with the lowest cover-
age and highest RMSE; this coincided with frequent failure
of this method to return estimates.
Repeating scenario I with a larger sample size (60 000
subjects) showed a comparable relative pattern as before
(Figure 2; Appendix Table 5, available as Supplementary
data at IJE online). Repeating scenario I using a one-stage
meta-analysis (20 000 subjects) improved performance.
There was no difference between the methods in mean OR,
bias or RMSE (Appendix Table 6, available as
Supplementary data at IJE online); even in extreme set-
tings, bias was low at -0.016 (MAF of 0.005 or F-statistic
of 4). Coverage (Figure 3) was generally close to 0.95 or
slightly larger, and agreement between mean SE and ESE
was generally good, only deviating at a MAF of 0.005 or
an F-statistic of 4. A non-parametric bootstrap percentile
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confidence interval was evaluated, performing similarly to
other methods (coverage  0.95). Repeating scenario I
with between-study variance showed similar performance
as in the original fixed effect scenario (Appendix Table 7,
available as Supplementary data at IJE online), except for
more conservative coverage rates and DM2 being the most
biased estimator at MAF  0.01, e.g. -0.257 mean bias at
MAF 0.005, which coincided with a coverage rate of al-
most 1, and a RMSE of 10.289. DM1 performed better
than other methods with a coverage of 0.981 and an
RMSE of 0.127, at a MAF of 0.005.
The Toby Johnson [TJ] variance estimator performed
comparably to the DM1 or DM2 in scenario I with only
slightly lower coverage (Appendix Table 8, available as
Supplementary data at IJE online). Implementing the delta
method by replacing the asymptotic variance estimators
with bootstrapped estimators [DM BB] performed simi-
larly to the BB method (Appendix Table 8). Repeating
scenario I with a continuous outcome revealed a com-
parable relative performance of the variance estimators
(Appendix Table 9, available as Supplementary data at IJE
online).
The LDL-C effect on CVD
Table 2 shows empirical results of two different IVs in a
six-study meta-analysis to estimate the effect of LDL-C on
CVD (see Appendix at IJE online for a description of the
data sources, and baseline data). Using SNP rs11591147 as
an IV (mean F-statistic ¼ 13.42) in a two-stage meta-ana-
lysis showed that the bootstrap methods had the largest
standard errors and their point estimates not only dis-
agreed with results from the remaining variance estimators
but also between themselves. As expected, using a one-
stage meta-analysis increased precision and decreased dif-
ferences between methods, resulting in an IV estimate of
0.93 (95% CI 0.50;1.72). Results from the weak instru-
ment rs2965101 (mean F-statistic ¼ 1.34) revealed large
differences between the bootstrap estimators and the re-
maining estimators; the minimal bootstrap SE estimate
Figure 1. Simulation results from scenarios I comparing different IV variance estimators. *Solid line with a square symbol, delta method followed by
meta-analysis [DM1]; solid line with a circle symbol, basic bootstrap [BB]; solid line with triangle symbol, outcome-stratified bootstrap [OS]; solid line
with a plus symbol, SNP-stratified bootstrap [SS]; solid line with a filled-out square symbol, double bootstrap [DB]; solid line with a filled-out circle
symbol, jack-knife estimator [JK]; solid line with a filled-out triangle symbol, robust variance estimator [RB]; solid line with a rhombus (diamond)
symbol, meta-analysis followed by delta method [DM2]. The DB y-value of 2.071 is not depicted for an MAF of 0.005 on the bottom left graph.
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was 13.19, compared with an SE of 1.49 using DM2.
Precision increased using a one-stage meta-analysis, how-
ever the bootstrapped SE were still comparatively large.
Given that one-stage meta-analyses are analysed by a single
analyst, it becomes practical to explore the bootstrap dis-
tributions (Figure 4). After omitting a number of outliers,
the bootstrap became relatively symmetrical and the SE es-
timates were: 1.27 (BB), 1.29 (OS), 1.33 (SS) and 3.51
(DB). The large SE of the DB and its truncated distribution
show that 50 times 250 repetitions were insufficient in this
setting.
Discussion
This study showed that, depending on the strength of the
IV and/or the outcome incidence, there is considerable dif-
ference in the performance of instrumental variable (IV)
variance estimators in two-stage meta-analysis. The delta
method (DM) showed the least amount of bias and the
best coverage, with the delta method implemented before
meta-analysis performing better in the presence of be-
tween-study variance. Bootstrap and robust variance esti-
mators (RB) produced extreme estimates in two-stage
meta-analysis. Differences between methods were minimal
using a one-stage meta-analysis, all providing unbiased es-
timates and appropriate coverage. An empirical example
on the LDL-C effect on CVD incidence confirmed that
these issues also occur in applied settings. Relative per-
formance of the variance estimators was similar when
using a continuous outcome instead of a binary endpoint.
At lower MAF/F-statistic values or lower outcome proba-
bilities, the RB estimators often failed to converge, making
it difficult to evaluate whether the underperformance of RB
was due to the estimator itself or to informative failures.
Looking at the JK (which failed in less than 1% of the simu-
lations, and which is an approximation of the HC3; which
is a refinement of the HC1 used in the RB), it seems that to
some extent this underperformance of the RB may be ex-
plained by computational problems in the R sandwich pack-
age.23 Following the usual practice in applied Mendelian
Figure 2. Sensitivity analysis repeating simulation I comparing different IV variance estimators with an average of 60 000 subjects. *Solid line with a
square symbol, delta method followed by meta-analysis [DM1]; solid line with a circle symbol, basic bootstrap [BB]; solid line with triangle symbol,
outcome-stratified bootstrap [OS]; solid line with a plus symbol, SNP-stratified bootstrap [SS]; solid line with a filled-out square symbol, double boot-
strap [DB]; solid line with a filled-out circle symbol, jack-knife estimator [JK]; solid line with a filled-out triangle symbol, robust variance estimator
[RB]; solid line with a rhombus (diamond) symbol, meta-analysis followed by delta method [DM2].
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Figure 3. Sensitivity analysis repeating simulation I comparing different IV variance estimators using a one-stage meta-analysis design with an aver-
age of 20 000 subjects. *Solid line with a square symbol, delta method followed by meta-analysis [DM1]; solid line with a circle symbol, basic boot-
strap [BB]; solid line with triangle symbol, outcome-stratified bootstrap [OS]; solid line with a plus symbol, SNP-stratified bootstrap [SS]; solid line
with a filled-out square symbol, double bootstrap [DB]; solid line with a filled-out circle symbol, jack-knife estimator [JK]; solid line with a filled-out tri-
angle symbol, robust variance estimator [RB]; solid line with a star symbol, bootstrapped percentile method. The BB y-value of -13.463 is not depicted
for an MAF of 0.005 on the right graph.
Figure 4. Bootstrap distributions for IV rs2965101 for the relation of LDL-C and CVD. *Solid grey lines indicate the non-parametric density (only pre-
sented in the second row), with dashed grey lines indicating the expected density given a normal distribution (not presented for the double
bootstrap).
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randomization analyses, the ratio and the TSLS point esti-
mators were used. Additionally to the usual three IV as-
sumptions, these point estimators also assume the
phenotype to be normally distributed conditional on the
SNP and confounders and homogeneity of the phenotype
(X) effect on the outcome.24 In our simulations these as-
sumptions held; however in applied settings this is not neces-
sarily the case, given that confounders are often unmeasured
these assumptions are also impossible to evaluate. Instead of
making these assumptions, different estimators or estimands
may be considered in empirical settings. For example, struc-
tural mean models, or generalized method of moments point
estimators or the risk difference estimand8,24 make fewer
assumptions.
Our results underline the difficulty of using the
observed F-statistic7 as a measure of expected bias due to a
weak instrument. We observed an increased performance
in a one-stage meta-analysis with on average 20 000 sub-
jects and a ‘weak’ instrument (MAF 0.05, mean F-statistic
5.97), compared with a two-stage meta-analysis with on
average 60 000 subjects and a ‘strong’ instrument (MAF
0.05, mean F-statistic 15.98). When conducting a one-
stage meta-analysis, results do not have to be pooled by the
inverse of an estimated study-specific variance. Therefore
in this scenario, point estimates, precision (ESE) and
RMSEs were not influenced by the choice of variance esti-
mators. The choice of variance estimator did influence
coverage, which was nevertheless markedly improved over
a two-stage design.
The underperformance of the bootstrap estimators in
the two-stage meta-analysis may come as a surprise to
some; however, the improved performance (over for ex-
ample a Wald-based confidence interval) shown in the lit-
erature mostly holds for bootstrap confidence intervals
such as the bias corrected and accelerated bootstrapped
confidence interval.17,22,25 Because of the need for a vari-
ance estimate in the second stage of a two-stage meta-ana-
lysis, the bootstrap can only be used to estimate the
standard error of the IV estimate, which implicitly assumes
symmetry of the bootstrap distribution.17,22,25 We did
however evaluate the percentile method to directly esti-
mate the confidence interval when we replicated scenario I
using a one-stage meta-analysis. Results indeed showed
proper coverage; however, this was similar to the increased
performance of all other estimators. We evaluated a delta
method estimator replacing the asymptotic variance esti-
mates by bootstrapped variance estimates; this approach
performed worse than the regular delta method (DM1 or
DM2). These results show that even though the asymptotic
approximations of br 2c1 and br2a1 do not strictly hold, these
estimates are better approximations (in such situations)
than bootstrapped alternatives.
The simulations presented here are naturally limited
and the following points merit discussion. First, different
simulation parameters will result in different absolute per-
formance. Instead, we focused on relative (i.e. between
methods) performance which we expect to be more robust.
Second, by fixing the effect of the instrument (the SNP) on
the phenotype, the instrument strength decreases with
MAF; hence our results include analyses with F-statistics
below 10. These are analyses, some might argue, an
applied researcher would not perform due to violation of
IV assumption 1. We showed, however, that despite the
‘weak’ instrument, valid estimates can be derived. Third,
although it seems logical to increase the number of boot-
straps as the data become sparser (or the IV becomes
weaker), we kept the number fixed to preserve comparabil-
ity between scenarios. Fourth, for simplicity we focused on
scenarios with a single SNP instrument whereas, to prevent
weak-instrument bias, most Mendelian randomization
studies use multiple SNPs. Nevertheless, relevant informa-
tion for these multiple SNP approaches can be found in
our analyses by focusing on strong-instrument settings.
Fifth, we only explored performance under the null [i.e.
OR¼ 1] because (i) coverage was often too low, making
comparisons on power pointless, and (ii) we wished to pre-
vent influence of non-collapsibility.26 Sixth, the small ORs
observed in low-frequency scenarios were most likely due
to the outcome being constant for a certain allele number
(i.e. perfect separation). In these settings, penalized models,
using for example a Firth27,28 or Lasso29 penalization, are
expected to perform better.30 Finally, random effects or
fixed effect analysis models were used depending on
whether the simulation scenario included between-study
variance or not.31 In empirical analyses, the choice be-
tween random effects and fixed effect models typically de-
pends on a heterogeneity measure.32 However, bias in
point and variance estimates will influence the observed
heterogeneity, resulting in different modelling choices de-
pending on the performance of the estimator. This would
make between-methods comparisons difficult. Therefore,
the choice of model was based on the true, rather than the
observed, between-study variance.
In conclusion, the choice of variance estimator in instru-
mental variable analyses using a two-stage meta-analysis is
important. Simulations showed that the delta method
applied at stage one of the two-stage meta-analysis
performed best. If resampling variance estimators are used,
we suggest always checking study-specific plots of these
distributions for outliers. This is especially important if the
outcome and/or SNPs are rare or if the instrument is weak.
Out of all the resampling methods, the jack-knife estimator
performed best. However, in such a scenario an even bet-
ter alternative, when possible, is to perform a one-stage
10 International Journal of Epidemiology, 2016, Vol. 00, No. 00
meta-analysis making the choice of variance estimator less
influential. If a one-stage design is used, resampling tech-
niques can be used to directly estimate confidence intervals
for which methods exist that do not assume a symmetrical
distribution (e.g. the percentile method).
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